QURE — uniQure N.V.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on QURE
| date | signal | measured base rate |
|---|---|---|
| 2026-08-10 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
| 2026-07-30 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-06-25 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-12 | Cluster sale: three or more insiders insider | -0.37% over 21 days · t = -3.38 · n = 21,542 statistically distinguishable from its control group |
| 2026-05-07 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-05-04 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-02 | Kapusta Matthew C CEO, Managing Director | Option exercise 10b5-1 plan | 21.1K | 19.39 | 408.8K |
| 2026-07-02 | Kapusta Matthew C CEO, Managing Director | Open-market sale 10b5-1 plan | 9.2K | 44.43 | 408.8K |
| 2026-07-02 | Kapusta Matthew C CEO, Managing Director | Open-market sale 10b5-1 plan | 7.6K | 45.89 | 348.8K |
| 2026-07-02 | Kapusta Matthew C CEO, Managing Director | Open-market sale 10b5-1 plan | 4.3K | 45.43 | 194.5K |
| 2026-06-30 | Abi-Saab Walid Chief Medical Officer | Open-market sale 10b5-1 plan | 20.0K | 46.40 | 928.0K |
| 2026-06-30 | Kaye Jack Director | Open-market sale 10b5-1 plan | 17.1K | 46.43 | 792.1K |
| 2026-06-30 | Abi-Saab Walid Chief Medical Officer | Open-market sale 10b5-1 plan | 10.0K | 46.46 | 464.6K |
| 2026-06-30 | Kaye Jack Director | Option exercise 10b5-1 plan | 17.1K | 20.18 | 344.3K |
| 2026-06-30 | Kaye Jack Director | Open-market sale 10b5-1 plan | 4.1K | 46.49 | 190.9K |
| 2026-06-30 | Kaye Jack Director | Option exercise 10b5-1 plan | 4.1K | 37.00 | 152.0K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Avoro Capital Advisors LLC | 97.4M | 6.0M |
| Aberdeen Group plc | 86.8M | 5.3M |
| TWO SIGMA INVESTMENTS, LP | 43.8M | 2.7M |
| RTW INVESTMENTS, LP | 42.3M | 2.6M |
| JPMORGAN CHASE & CO | 41.8M | 2.8M |
| STATE STREET CORP | 37.0M | 2.3M |
| ORBIMED ADVISORS LLC | 34.9M | 2.1M |
| FMR LLC | 28.5M | 1.7M |
| BlackRock, Inc. | 28.3M | 1.7M |
| MPM BIOIMPACT LLC | 22.4M | 1.4M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- 9 Health Care Stocks Whale Activity In Today’s Session · 2026-08-14 · benzinga
Ask the AI about QURE
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →